Table 2.
Summary of the effects of PMA on 8cpt-cAMP-induced responses in EBV-transformed lymphocytes
| Basal, nS | 8cpt-cAMP, nS | 8cpt-cAMP + PMA, nS | |
|---|---|---|---|
| Wild-type | |||
| Absence of chelerythrine | 0.40 ± 0.14 (12) | 1.42 ± 0.59 (12) | 0.38 ± 0.16* (9) |
| With chelerythrine | 0.32 ± 0.20 (4) | 1.33 ± 0.41 (4) | 1.10 ± 0.44 (4) |
| Heterozygous (overall, 24) | 0.46 ± 0.14 | 3.03 ± 1.38 | 1.99 ± 1.65* |
| Wild-type-like (5) | 0.51 ± 0.18 | 1.42 ± 0.38 | 0.54 ± 0.19* |
| “Intermediate” (14) | 0.44 ± 0.13 | 2.93 ± 0.78 | 1.51 ± 0.64* |
| Homozygous-like (5) | 0.47 ± 0.07 | 4.92 ± 1.06 | 4.79 ± 1.04 |
| Homozygous (16) | 0.52 ± 0.17 | 4.71 ± 1.28 | 4.60 ± 1.27 |
In the wild-type group, the presence of chelerythrine in the pipet solution significantly reduced the inhibition by PMA (P < 0.001) but had no effect on either the basal conductance or the response to 8cpt-cAMP. The values obtained for PMA are significantly different from the slope conductance values obtained with 8cpt-cyclic AMP alone with the exception of the homozygous-like and homozygous variant: ∗, P < 0.05. 8cpt-cAMP was applied intracellularly via the recording pipet.